Publications from OUS - Dept of Cardiology Ullevaal - RG Cardiology Intensive Care

121 publications found

1. Huse C, Murphy SL, Yang K, Balzer NR, Stokke MK, Anstensrud AK, Bjerkeli V, Rentz T, Jha PK, Ugland HK, Michelsen AE, Ueland T, Holm S, Tøllefsen IM, Bendz B, Kleveland O, Andersen GØ, Gullestad L, Louch WE, Woxholt S, Osnes L, Broch K, Ulas T, Aukrust P, Libby P et al. (2025)
   The effects of interleukin-6-receptor inhibition on monocytes in STEMI: a substudy of the ASSAIL-MI trial
   EBioMedicine, 121, 105960 (in press)
   DOI 10.1016/j.ebiom.2025.105960, PubMed 41076990
2. Jortveit J, Myhre PL, Andersen GØ, Halvorsen S (2025)
   Cardiogenic shock as a complication of acute myocardial infarction: a nationwide cohort study
   Eur Heart J Acute Cardiovasc Care (in press)
   DOI 10.1093/ehjacc/zuaf118, PubMed 40973608
3. Dahl TB, Quiles-Jiménez A, Broch K, Anstensrud AK, Gullestad L, Andersen GØ, Kleveland O, Øgaard J, Bjerkeli V, Rashidi A, Yang K, Holven KB, Aukrust P, Bjørås M, Huse C, Halvorsen B (2025)
   The N-6 methyladenosine dynamics in STEMI and the effect of IL-6 inhibition - a hypothesis generating sub-study of the ASSAIL-MI trial
   Front Immunol, 16, 1532325
   DOI 10.3389/fimmu.2025.1532325, PubMed 40547027
4. Grimholt TK, Gjesdal O, Bonsaksen T, Heir T, Ekeberg O, Schou Bredal I, Skogstad L, Tøllefsen IM (2025)
   Posttraumatic stress disorder symptoms in adults with congenital heart disease (ACHD) during the COVID-19 pandemic in Norway
   Int J Cardiol Congenit Heart Dis, 20, 100585
   DOI 10.1016/j.ijcchd.2025.100585, PubMed 40524978
5. Svedlund Eriksson E, Lantero Rodriguez M, Halvorsen B, Johansson I, Mårtensson AKF, Wilhelmson AS, Huse C, Ueland T, Aukrust P, Broch K, Gullestad L, Amundsen BH, Andersen GØ, Karlsson MCI, Hagberg Thulin M, Camponeschi A, Trompet D, Hammarsten O, Redfors B, Borén J, Omerovic E, Levin MC, Chagin AS, Dahl TB, Tivesten Å (2025)
   Testosterone exacerbates neutrophilia and cardiac injury in myocardial infarction via actions in bone marrow
   Nat Commun, 16 (1), 1142
   DOI 10.1038/s41467-025-56217-x, PubMed 39910039
6. Bruun LD, Andersen GØ, Kringen MK, Myhre PL, Halvorsen S, Hansen CH, Molden E, Øie E (2025)
   Effect of metoprolol exposure following myocardial infarction on future cardiovascular events: a Mendelian randomization study
   Eur J Clin Pharmacol, 81 (4), 551-560
   DOI 10.1007/s00228-025-03806-w, PubMed 39900827
7. Jortveit J, Andersen GØ, Halvorsen S (2024)
   Short- and long-term outcomes of patients with acute myocardial infarction complicated by cardiac arrest: a nationwide cohort study 2013-22
   Eur Heart J Acute Cardiovasc Care, 13 (12), 828-837
   DOI 10.1093/ehjacc/zuae121, PubMed 39441985
8. Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Damås JK, Kleveland O (2024)
   Effect of tocilizumab on endothelial and platelet-derived CXC-chemokines and their association with inflammation and myocardial injury in STEMI patients undergoing primary PCI
   Int J Cardiol, 418, 132613
   DOI 10.1016/j.ijcard.2024.132613, PubMed 39374793
9. Nendl A, Andersen GØ, Seljeflot I, Trøseid M, Awoyemi A (2024)
   Intestinal fatty acid binding protein is associated with infarct size and cardiac function in acute heart failure following myocardial infarction
   Open Heart, 11 (2)
   DOI 10.1136/openhrt-2024-002868, PubMed 39277188
10. Kindberg KM, Broch K, Andersen GØ, Anstensrud AK, Åkra S, Woxholt S, Tøllefsen IM, Ueland T, Amundsen BH, Kløw NE, Halvorsen B, Dahl TB, Huse C, Murphy SL, Damås JK, Opdahl A, Wiseth R, Gullestad L, Aukrust P, Santos-Gallego C, Seljeflot I, Stokke MK, Helseth R (2024)
    Neutrophil Extracellular Traps in ST-Segment Elevation Myocardial Infarction: Reduced by Tocilizumab and Associated With Infarct Size
    JACC Adv, 3 (9), 101193
    DOI 10.1016/j.jacadv.2024.101193, PubMed 39247678
11. Holme FA, Huse C, Kong XY, Broch K, Gullestad L, Anstensrud AK, Andersen GØ, Amundsen BH, Kleveland O, Quiles-Jimenez A, Holm S, Aukrust P, Alseth I, Halvorsen B, Dahl TB (2024)
    Circular RNA Profile in Atherosclerotic Disease: Regulation during ST-Elevated Myocardial Infarction
    Int J Mol Sci, 25 (16)
    DOI 10.3390/ijms25169014, PubMed 39201700
12. Melberg MB, Flaa A, Andersen GØ, Sunde K, Bellomo R, Eastwood G, Olasveengen TM, Qvigstad E (2024)
    Effects of mild hypercapnia on myocardial injury after out-of-hospital cardiac arrest. A sub-study of the TAME trial
    Resuscitation, 201, 110295
    DOI 10.1016/j.resuscitation.2024.110295, PubMed 38936652
13. Andrup S, Andersen GØ, Hoffmann P, Eritsland J, Seljeflot I, Halvorsen S, Vistnes M (2024)
    Novel cardiac extracellular matrix biomarkers in STEMI: Associations with ischemic injury and long-term mortality
    PLoS One, 19 (5), e0302732
    DOI 10.1371/journal.pone.0302732, PubMed 38739599
14. Kluge KE, Langseth MS, Andersen GØ, Halvorsen S, Opstad TB, Arnesen H, Tønnessen T, Seljeflot I, Helseth R (2022)
    Complement activation in association with clinical outcomes in ST-elevation myocardial infarction
    Am Heart J Plus, 24, 100228
    DOI 10.1016/j.ahjo.2022.100228, PubMed 38560636
15. Wimmer H, Stensønes SH, Benth JŠ, Lundqvist C, Andersen GØ, Draegni T, Sunde K, Nakstad ER (2023)
    Outcome prediction in comatose cardiac arrest patients with initial shockable and non-shockable rhythms
    Acta Anaesthesiol Scand, 68 (2), 263-273
    DOI 10.1111/aas.14337, PubMed 37876138
16. Reichenbach A, Alteheld L, Henriksen J, Nakstad ER, Andersen GØ, Sunde K, Šaltytė Benth J, Lundqvist C (2023)
    Transcranial Doppler during the first week after cardiac arrest and association with 6-month outcomes
    Front Neurol, 14, 1222401
    DOI 10.3389/fneur.2023.1222401, PubMed 37859655
17. Melberg MB, Flaa A, Andersen GØ, Sunde K, Bellomo R, Eastwood G, Olasveengen TM, Qvigstad E (2023)
    Cardiovascular changes induced by targeted mild hypercapnia after out of hospital cardiac arrest. A sub-study of the TAME cardiac arrest trial
    Resuscitation, 193, 109970
    DOI 10.1016/j.resuscitation.2023.109970, PubMed 37716401
18. Woxholt S, Ueland T, Aukrust P, Anstensrud AK, Broch K, Tøllefsen IM, Ryan L, Bendz B, Hopp E, Kløw NE, Seljeflot I, Halvorsen B, Dahl TB, Huse C, Andersen GØ, Gullestad L, Wiseth R, Amundsen BH, Damas JK, Kleveland O (2023)
    Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
    Open Heart, 10 (2)
    DOI 10.1136/openhrt-2023-002301, PubMed 37591633
19. Holt MF, Flø A, Bjørnø V, Husebye T, Knudsen EC, Hodt A, Gustavsen A, Kristiansen HA, Raki M, Broch K, Wien TN, Gude E (2023)
    A man in his seventies with fatigue and renal failure
    Tidsskr Nor Laegeforen, 143 (9)
    DOI 10.4045/tidsskr.22.0679, PubMed 37341412
20. Eastwood G, Nichol AD, Hodgson C, Parke RL, McGuinness S, Nielsen N, Bernard S, Skrifvars MB, Stub D, Taccone FS, Archer J, Kutsogiannis D, Dankiewicz J, Lilja G, Cronberg T, Kirkegaard H, Capellier G, Landoni G, Horn J, Olasveengen T, Arabi Y, Chia YW, Markota A, Hænggi M, Wise MP et al. (2023)
    Mild Hypercapnia or Normocapnia after Out-of-Hospital Cardiac Arrest
    N Engl J Med, 389 (1), 45-57
    DOI 10.1056/NEJMoa2214552, PubMed 37318140
21. Lyng CS, Gude E, Hodt A, Knudsen EC (2023)
    First Norwegian case of hereditary ATTR amyloidosis with a novel transthyretin variant
    Scand Cardiovasc J, 57 (1), 2174269
    DOI 10.1080/14017431.2023.2174269, PubMed 36734834
22. Fontaine MAC, Jin H, Gagliardi M, Rousch M, Wijnands E, Stoll M, Li X, Schurgers L, Reutelingsperger C, Schalkwijk C, van den Akker NMS, Molin DGM, Gullestad L, Eritsland J, Hoffman P, Skjelland M, Andersen GØ, Aukrust P, Karel J, Smirnov E, Halvorsen B, Temmerman L, Biessen EAL (2022)
    Blood Milieu in Acute Myocardial Infarction Reprograms Human Macrophages for Trauma Repair
    Adv Sci (Weinh), 10 (5), e2203053
    DOI 10.1002/advs.202203053, PubMed 36526599
23. Wimmer H, Benth JŠ, Lundqvist C, Andersen GØ, Henriksen J, Drægni T, Solberg P, Stær-Jensen H, Sunde K, Nakstad ER (2022)
    Changes in health status and health related quality of life from six months to five years in out-of-hospital cardiac arrest survivors - A NORCAST sub study
    Resuscitation, 181, 182-189
    DOI 10.1016/j.resuscitation.2022.08.019, PubMed 36084805
24. Huse C, Anstensrud AK, Michelsen AE, Ueland T, Broch K, Woxholt S, Yang K, Sharma K, Tøllefsen IM, Bendz B, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Quiles-Jiménez A, Bjerkeli V, Bendz C, Kleveland O, Stensaeth KH, Opdahl A, Kløw NE, Andersen GØ, Wiseth R, Halvorsen B, Gullestad L et al. (2022)
    Interleukin-6 inhibition in ST-elevation myocardial infarction: Immune cell profile in the randomised ASSAIL-MI trial
    EBioMedicine, 80, 104013
    DOI 10.1016/j.ebiom.2022.104013, PubMed 35504178
25. Tøllefsen IM, Shetelig C, Seljeflot I, Eritsland J, Hoffmann P, Andersen GØ (2021)
    High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
    Open Heart, 8 (2)
    DOI 10.1136/openhrt-2021-001869, PubMed 34933964
26. Andersen GØ (2022)
    Comments on-The noradrenaline dosing in the new 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
    Eur Heart J Cardiovasc Pharmacother, 8 (3), E11
    DOI 10.1093/ehjcvp/pvab086, PubMed 34918059
27. Thomas AM, Chaban V, Pischke SE, Orrem HL, Bosnes V, Sunde K, Seljeflot I, Lundqvist C, Nakstad ER, Andersen GØ, Schjalm C, Mollnes TE, Barratt-Due A (2021)
    Complement ratios C3bc/C3 and sC5b-9/C5 do not increase the sensitivity of detecting acute complement activation systemically
    Mol Immunol, 141, 273-279
    DOI 10.1016/j.molimm.2021.11.016, PubMed 34906905
28. Broch K, Anstensrud AK, Woxholt S, Andersen GØ, Gullestad L (2021)
    Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial
    J Am Coll Cardiol, 78 (6), 637-638
    DOI 10.1016/j.jacc.2021.06.005, PubMed 34353542
29. Chaban V, Nakstad ER, Stær-Jensen H, Schjalm C, Seljeflot I, Vaage J, Lundqvist C, Benth JŠ, Sunde K, Mollnes TE, Andersen GØ, Pischke SE (2021)
    Complement activation is associated with poor outcome after out-of-hospital cardiac arrest
    Resuscitation, 166, 129-136
    DOI 10.1016/j.resuscitation.2021.05.038, PubMed 34126135
30. Broch K, Anstensrud AK, Woxholt S, Sharma K, Tøllefsen IM, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Berg ES, Bjørkelund E, Bendz C, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2021)
    Randomized Trial of Interleukin-6 Receptor Inhibition in Patients With Acute ST-Segment Elevation Myocardial Infarction
    J Am Coll Cardiol, 77 (15), 1845-1855
    DOI 10.1016/j.jacc.2021.02.049, PubMed 33858620
31. Alm-Kruse K, Sørensen G, Osbakk SA, Sunde K, Bendz B, Andersen GØ, Fiane A, Hagen OA, Kramer-Johansen J (2021)
    Outcome in refractory out-of-hospital cardiac arrest before and after implementation of an ECPR protocol
    Resuscitation, 162, 35-42
    DOI 10.1016/j.resuscitation.2021.01.038, PubMed 33581226
32. Wimmer H, Lundqvist C, Šaltytė Benth J, Stavem K, Andersen GØ, Henriksen J, Drægni T, Sunde K, Nakstad ER (2021)
    Health-related quality of life after out-of-hospital cardiac arrest – a five-year follow-up study
    Resuscitation, 162, 372-380
    DOI 10.1016/j.resuscitation.2021.01.036, PubMed 33571604
33. Voll M, Øystese KA, Høiskar E, Johansen O, Nyvold C, Norheim I, von Lueder TG, Andersen GØ (2021)
    Case report: a patient with thyroid storm, refractory cardiogenic shock, and cardiac arrest treated with Lugol's iodine solution and veno-arterial extra corporal membrane oxygenation support
    Eur Heart J Case Rep, 5 (2), ytab017
    DOI 10.1093/ehjcr/ytab017, PubMed 33569532
34. Tollisen KH, Hadley CL, Bjerva M, Dahl GT, Högvall LM, Sandvik L, Andersen GØ, Heyerdahl F, Jacobsen D (2020)
    Clinical impact of chronic substance abuse in a Norwegian ICU-population
    Acta Anaesthesiol Scand, 65 (4), 515-524
    DOI 10.1111/aas.13766, PubMed 33340102
35. Langseth MS, Andersen GØ, Husebye T, Arnesen H, Zucknick M, Solheim S, Eritsland J, Seljeflot I, Opstad TB, Helseth R (2020)
    Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure
    PLoS One, 15 (10), e0241333
    DOI 10.1371/journal.pone.0241333, PubMed 33119664
36. Niyonzima N, Bakke SS, Gregersen I, Holm S, Sandanger Ø, Orrem HL, Sporsheim B, Ryan L, Kong XY, Dahl TB, Skjelland M, Sørensen KK, Rokstad AM, Yndestad A, Latz E, Gullestad L, Andersen GØ, Damås JK, Aukrust P, Mollnes TE, Halvorsen B, Espevik T (2020)
    Cholesterol crystals use complement to increase NLRP3 signaling pathways in coronary and carotid atherosclerosis
    EBioMedicine, 60, 102985
    DOI 10.1016/j.ebiom.2020.102985, PubMed 32927275
37. Sandven I, Eritsland J, Abdelnoor M (2020)
    Remote Ischemic Conditioning in Patients with Acute Coronary Syndromes: A Systematic Review with Meta-Analysis and Trial Sequential Analysis
    Clin Epidemiol, 12, 595-605
    DOI 10.2147/CLEP.S249785, PubMed 32606985
38. Langseth MS, Helseth R, Ritschel V, Hansen CH, Andersen GØ, Eritsland J, Halvorsen S, Fagerland MW, Solheim S, Arnesen H, Seljeflot I, Opstad TB (2020)
    Double-Stranded DNA and NETs Components in Relation to Clinical Outcome After ST-Elevation Myocardial Infarction
    Sci Rep, 10 (1), 5007
    DOI 10.1038/s41598-020-61971-7, PubMed 32193509
39. Trøseid M, Andersen GØ, Broch K, Hov JR (2020)
    The gut microbiome in coronary artery disease and heart failure: Current knowledge and future directions
    EBioMedicine, 52, 102649
    DOI 10.1016/j.ebiom.2020.102649, PubMed 32062353
40. Nakstad ER, Stær-Jensen H, Wimmer H, Henriksen J, Alteheld LH, Reichenbach A, Drægni T, Šaltytė-Benth J, Wilson JA, Etholm L, Øijordsbakken M, Eritsland J, Seljeflot I, Jacobsen D, Andersen GØ, Lundqvist C, Sunde K (2020)
    Late awakening, prognostic factors and long-term outcome in out-of-hospital cardiac arrest - results of the prospective Norwegian Cardio-Respiratory Arrest Study (NORCAST)
    Resuscitation, 149, 170-179
    DOI 10.1016/j.resuscitation.2019.12.031, PubMed 31926258
41. Lunde NN, Gregersen I, Ueland T, Shetelig C, Holm S, Kong XY, Michelsen AE, Otterdal K, Yndestad A, Broch K, Gullestad L, Nyman TA, Bendz B, Eritsland J, Hoffmann P, Skagen K, Gonçalves I, Nilsson J, Grenegård M, Poreba M, Drag M, Seljeflot I, Sporsheim B, Espevik T, Skjelland M et al. (2019)
    Legumain is upregulated in acute cardiovascular events and associated with improved outcome - potentially related to anti-inflammatory effects on macrophages
    Atherosclerosis, 296, 74-82
    DOI 10.1016/j.atherosclerosis.2019.12.008, PubMed 31870625
42. Karlsen H, Bergan HA, Halvorsen PS, Sunde K, Qvigstad E, Andersen GØ, Bugge JF, Olasveengen TM (2019)
    Esmolol for cardioprotection during resuscitation with adrenaline in an ischaemic porcine cardiac arrest model
    Intensive Care Med Exp, 7 (1), 65
    DOI 10.1186/s40635-019-0279-5, PubMed 31802327
43. Helseth R, Shetelig C, Andersen GØ, Langseth MS, Limalanathan S, Opstad TB, Arnesen H, Hoffmann P, Eritsland J, Seljeflot I (2019)
    Neutrophil Extracellular Trap Components Associate with Infarct Size, Ventricular Function, and Clinical Outcome in STEMI
    Mediators Inflamm, 2019, 7816491
    DOI 10.1155/2019/7816491, PubMed 31772506
44. Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S (2019)
    Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study
    Cardiology, 144 (3-4), 79-89
    DOI 10.1159/000503442, PubMed 31689705
45. Pollesello P, Ben Gal T, Bettex D, Cerny V, Comin-Colet J, Eremenko AA, Farmakis D, Fedele F, Fonseca C, Harjola VP, Herpain A, Heringlake M, Heunks L, Husebye T, Ivancan V, Karason K, Kaul S, Kubica J, Mebazaa A, Mølgaard H, Parissis J, Parkhomenko A, Põder P, Pölzl G, Vrtovec B et al. (2019)
    Short-Term Therapies for Treatment of Acute and Advanced Heart Failure-Why so Few Drugs Available in Clinical Use, Why Even Fewer in the Pipeline?
    J Clin Med, 8 (11)
    DOI 10.3390/jcm8111834, PubMed 31683969
46. Anstensrud AK, Woxholt S, Sharma K, Broch K, Bendz B, Aakhus S, Ueland T, Amundsen BH, Damås JK, Hopp E, Kleveland O, Stensæth KH, Opdahl A, Kløw NE, Seljeflot I, Andersen GØ, Wiseth R, Aukrust P, Gullestad L (2019)
    Rationale for the ASSAIL-MI-trial: a randomised controlled trial designed to assess the effect of tocilizumab on myocardial salvage in patients with acute ST-elevation myocardial infarction (STEMI)
    Open Heart, 6 (2), e001108
    DOI 10.1136/openhrt-2019-001108, PubMed 31673391
47. Helseth R, Knudsen EC, Eritsland J, Opstad TB, Arnesen H, Andersen GØ, Seljeflot I (2019)
    Glucose associated NETosis in patients with ST-elevation myocardial infarction: an observational study
    BMC Cardiovasc Disord, 19 (1), 221
    DOI 10.1186/s12872-019-1205-1, PubMed 31615411
48. Knudsen EC, Seljeflot I, Aksnes TA, Eritsland J, Arnesen H, Andersen GØ (2019)
    IgM antibodies against phosphorylcholine measured early after acute ST-elevation myocardial infarction in relation to atherosclerotic disease burden and long-term clinical outcome
    PLoS One, 14 (4), e0215640
    DOI 10.1371/journal.pone.0215640, PubMed 31002684
49. Hov KR, Neerland BE, Undseth Ø, Wyller VBB, MacLullich AMJ, Qvigstad E, Skovlund E, Wyller TB (2019)
    The Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
    Int J Geriatr Psychiatry, 34 (7), 974-981
    DOI 10.1002/gps.5098, PubMed 30901487
50. Braathen B, Husebye T, Lunde IG, Tønnessen T (2018)
    Trifecta has lower gradient and less prosthesis-patient mismatch than Mosaic Ultra in the aortic position: A prospective randomized study
    J Thorac Cardiovasc Surg, 158 (4), 1032-1039
    DOI 10.1016/j.jtcvs.2018.11.020, PubMed 30635187
51. Bethke A, Shanmuganathan L, Shetelig C, Swanson D, Andersen GØ, Eritsland J, Kløw NE, Hoffmann P (2018)
    MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI
    PLoS One, 13 (11), e0206723
    DOI 10.1371/journal.pone.0206723, PubMed 30412607
52. Røe ÅT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Nordén ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GØ, Sjaastad I, Louch WE (2019)
    Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
    Cardiovasc Res, 115 (4), 752-764
    DOI 10.1093/cvr/cvy257, PubMed 30351410
53. Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE (2018)
    IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction
    Front Immunol, 9, 2035
    DOI 10.3389/fimmu.2018.02035, PubMed 30258440
54. Hiis HG, Cosson MV, Dahl CP, Fiane AE, Levy FO, Andersen GØ, Krobert KA (2018)
    Hypothermia elongates the contraction-relaxation cycle in explanted human failing heart decreasing the time for ventricular filling during diastole
    Am J Physiol Heart Circ Physiol, 315 (5), H1137-H1147
    DOI 10.1152/ajpheart.00208.2018, PubMed 30004809
55. Bethke A, Shanmuganathan L, Andersen GØ, Eritsland J, Swanson D, Kløw NE, Hoffmann P (2018)
    Microvascular perfusion in infarcted and remote myocardium after successful primary PCI: angiographic and CMR findings
    Eur Radiol, 29 (2), 941-950
    DOI 10.1007/s00330-018-5588-7, PubMed 29980929
56. Shetelig C, Limalanathan S, Hoffmann P, Seljeflot I, Gran JM, Eritsland J, Andersen GØ (2018)
    Association of IL-8 With Infarct Size and Clinical Outcomes in Patients With STEMI
    J Am Coll Cardiol, 72 (2), 187-198
    DOI 10.1016/j.jacc.2018.04.053, PubMed 29976293
57. Hov KR, Neerland BE, Andersen AM, Undseth Ø, Wyller VB, MacLullich AMJ, Skovlund E, Qvigstad E, Wyller TB (2018)
    The use of clonidine in elderly patients with delirium; pharmacokinetics and hemodynamic responses
    BMC Pharmacol Toxicol, 19 (1), 29
    DOI 10.1186/s40360-018-0218-1, PubMed 29884231
58. Orrem HL, Shetelig C, Ueland T, Limalanathan S, Nilsson PH, Husebye T, Aukrust P, Seljeflot I, Hoffmann P, Eritsland J, Mollnes TE, Andersen GØ, Yndestad A (2018)
    Soluble IL-1 receptor 2 is associated with left ventricular remodelling in patients with ST-elevation myocardial infarction
    Int J Cardiol, 268, 187-192
    DOI 10.1016/j.ijcard.2018.05.032, PubMed 29853279
59. Hansen CH, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Seljeflot I (2018)
    Markers of Thrombin Generation Are Associated With Long-Term Clinical Outcome in Patients With ST-Segment Elevation Myocardial Infarction
    Clin Appl Thromb Hemost, 24 (7), 1088-1094
    DOI 10.1177/1076029618764847, PubMed 29695176
60. Staer-Jensen H, Sunde K, Nakstad ER, Eritsland J, Andersen GØ (2018)
    Comparison of three haemodynamic monitoring methods in comatose post cardiac arrest patients
    Scand Cardiovasc J, 52 (3), 141-148
    DOI 10.1080/14017431.2018.1450992, PubMed 29544369
61. Orrem HL, Nilsson PH, Pischke SE, Grindheim G, Garred P, Seljeflot I, Husebye T, Aukrust P, Yndestad A, Andersen GØ, Barratt-Due A, Mollnes TE (2018)
    Acute heart failure following myocardial infarction: complement activation correlates with the severity of heart failure in patients developing cardiogenic shock
    ESC Heart Fail, 5 (3), 292-301
    DOI 10.1002/ehf2.12266, PubMed 29424484
62. Kvakkestad KM, Sandvik L, Andersen GØ, Sunde K, Halvorsen S (2017)
    Long-term survival in patients with acute myocardial infarction and out-of-hospital cardiac arrest: A prospective cohort study
    Resuscitation, 122, 41-47
    DOI 10.1016/j.resuscitation.2017.11.047, PubMed 29155294
63. Ritschel V, Shetelig C, Seljeflot I, Limalanathan S, Hoffmann P, Halvorsen S, Arnesen H, Eritsland J, Andersen GØ (2017)
    Evaluation of circulating levels of CCN2/connective tissue growth factor in patients with ST-elevation myocardial infarction
    Sci Rep, 7 (1), 11945
    DOI 10.1038/s41598-017-12372-w, PubMed 28931920
64. Meier S, Andressen KW, Aronsen JM, Sjaastad I, Hougen K, Skomedal T, Osnes JB, Qvigstad E, Levy FO, Moltzau LR (2017)
    PDE3 inhibition by C-type natriuretic peptide-induced cGMP enhances cAMP-mediated signaling in both non-failing and failing hearts
    Eur J Pharmacol, 812, 174-183
    DOI 10.1016/j.ejphar.2017.07.014, PubMed 28697992
65. Kvakkestad KM, Wang Fagerland M, Eritsland J, Halvorsen S (2017)
    Gender differences in all-cause, cardiovascular and cancer mortality during long-term follow-up after acute myocardial infarction; a prospective cohort study
    BMC Cardiovasc Disord, 17 (1), 75
    DOI 10.1186/s12872-017-0508-3, PubMed 28288586
66. Shetelig C, Limalanathan S, Eritsland J, Hoffmann P, Seljeflot I, Gran JM, Aukrust P, Ueland T, Andersen GØ (2017)
    Osteoprotegerin levels in ST-elevation myocardial infarction: Temporal profile and association with myocardial injury and left ventricular function
    PLoS One, 12 (3), e0173034
    DOI 10.1371/journal.pone.0173034, PubMed 28253327
67. Husebye T, Eritsland J, Bjørnerheim R, Andersen GØ (2017)
    Systolic mitral annulus velocity is a sensitive index for changes in left ventricular systolic function during inotropic therapy in patients with acute heart failure
    Eur Heart J Acute Cardiovasc Care, 7 (4), 321-329
    DOI 10.1177/2048872616687114, PubMed 28045338
68. Chiva-Blanch G, Bratseth V, Ritschel V, Andersen GØ, Halvorsen S, Eritsland J, Arnesen H, Badimon L, Seljeflot I (2016)
    Monocyte-derived circulating microparticles (CD14⁺, CD14⁺/CD11b⁺ and CD14⁺/CD142⁺) are related to long-term prognosis for cardiovascular mortality in STEMI patients
    Int J Cardiol, 227, 876-881
    DOI 10.1016/j.ijcard.2016.11.302, PubMed 27915085
69. Beitland S, Waldum-Grevbo BE, Nakstad ER, Berg JP, Trøseid AS, Brusletto BS, Brunborg C, Andersen GØ, Sunde K (2016)
    Urine biomarkers give early prediction of acute kidney injury and outcome after out-of-hospital cardiac arrest
    Crit Care, 20 (1), 314
    DOI 10.1186/s13054-016-1503-2, PubMed 27716377
70. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Eritsland J, Fagerland MW, Andersen GØ (2016)
    Circulating Levels of IL-6 Receptor and gp130 and Long-Term Clinical Outcomes in ST-Elevation Myocardial Infarction
    J Am Heart Assoc, 5 (6)
    DOI 10.1161/JAHA.115.003014, PubMed 27412895
71. Beitland S, Nakstad ER, Staer-Jensen H, Draegni T, Andersen GØ, Jacobsen D, Brunborg C, Waldum-Grevbo B, Sunde K (2016)
    Impact of acute kidney injury on patient outcome in out-of-hospital cardiac arrest: a prospective observational study
    Acta Anaesthesiol Scand, 60 (8), 1170-81
    DOI 10.1111/aas.12753, PubMed 27306254
72. Næss PA, Engeseth K, Grøtta O, Andersen GØ, Gaarder C (2016)
    Minimal invasive treatment of life-threatening bleeding caused by cardiopulmonary resuscitation-associated liver injury: a case report
    J Med Case Rep, 10 (1), 132
    DOI 10.1186/s13256-016-0926-3, PubMed 27236329
73. Nieminen MS, Buerke M, Cohen-Solál A, Costa S, Édes I, Erlikh A, Franco F, Gibson C, Gorjup V, Guarracino F, Gustafsson F, Harjola VP, Husebye T, Karason K, Katsytadze I, Kaul S, Kivikko M, Marenzi G, Masip J, Matskeplishvili S, Mebazaa A, Møller JE, Nessler J, Nessler B, Ntalianis A et al. (2016)
    The role of levosimendan in acute heart failure complicating acute coronary syndrome: A review and expert consensus opinion
    Int J Cardiol, 218, 150-157
    DOI 10.1016/j.ijcard.2016.05.009, PubMed 27232927
74. Sunde K, Andersen GØ (2015)
    Prediction of outcome after out-of-hospital cardiac arrest already on hospital admission-not reliable enough to be true!
    Eur Heart J, 37 (42), 3229-3231
    DOI 10.1093/eurheartj/ehv490, PubMed 26516178
75. Stær-Jensen H, Nakstad ER, Fossum E, Mangschau A, Eritsland J, Drægni T, Jacobsen D, Sunde K, Andersen GØ (2015)
    Post-Resuscitation ECG for Selection of Patients for Immediate Coronary Angiography in Out-of-Hospital Cardiac Arrest
    Circ Cardiovasc Interv, 8 (10)
    DOI 10.1161/CIRCINTERVENTIONS.115.002784, PubMed 26453688
76. Halvorsen B, Espeland MZ, Andersen GØ, Yndestad A, Sagen EL, Rashidi A, Knudsen EC, Skjelland M, Skagen KR, Krohg-Sørensen K, Holm S, Ritschel V, Holven KB, Biessen EA, Aukrust P, Dahl TB (2015)
    Increased expression of NAMPT in PBMC from patients with acute coronary syndrome and in inflammatory M1 macrophages
    Atherosclerosis, 243 (1), 204-10
    DOI 10.1016/j.atherosclerosis.2015.09.010, PubMed 26402139
77. Hansen CH, Ritschel V, Halvorsen S, Andersen GØ, Bjørnerheim R, Eritsland J, Arnesen H, Seljeflot I (2015)
    Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
    Thromb J, 13, 31
    DOI 10.1186/s12959-015-0061-1, PubMed 26396552
78. Neerland BE, Hov KR, Bruun Wyller V, Qvigstad E, Skovlund E, MacLullich AM, Bruun Wyller T (2015)
    The protocol of the Oslo Study of Clonidine in Elderly Patients with Delirium; LUCID: a randomised placebo-controlled trial
    BMC Geriatr, 15, 7
    DOI 10.1186/s12877-015-0006-3, PubMed 25887557
79. Kvakkestad KM, Abdelnoor M, Claussen PA, Eritsland J, Fossum E, Halvorsen S (2015)
    Long-term survival in octogenarians and older patients with ST-elevation myocardial infarction in the era of primary angioplasty: A prospective cohort study
    Eur Heart J Acute Cardiovasc Care, 5 (3), 243-52
    DOI 10.1177/2048872615574706, PubMed 25753053
80. Ørstavik Ø, Manfra O, Andressen KW, Andersen GØ, Skomedal T, Osnes JB, Levy FO, Krobert KA (2015)
    The inotropic effect of the active metabolite of levosimendan, OR-1896, is mediated through inhibition of PDE3 in rat ventricular myocardium
    PLoS One, 10 (3), e0115547
    DOI 10.1371/journal.pone.0115547, PubMed 25738589
81. Stær-Jensen H, Sunde K, Andersen GØ (2015)
    The authors reply
    Crit Care Med, 43 (3), e98
    DOI 10.1097/CCM.0000000000000812, PubMed 25700077
82. Claussen PA, Abdelnoor M, Kvakkestad KM, Eritsland J, Halvorsen S (2014)
    Prevalence of risk factors at presentation and early mortality in patients aged 80 years or older with ST-segment elevation myocardial infarction
    Vasc Health Risk Manag, 10, 683-9
    DOI 10.2147/VHRM.S72764, PubMed 25525366
83. Husebye T, Eritsland J, Arnesen H, Bjørnerheim R, Mangschau A, Seljeflot I, Andersen GØ (2014)
    Association of interleukin 8 and myocardial recovery in patients with ST-elevation myocardial infarction complicated by acute heart failure
    PLoS One, 9 (11), e112359
    DOI 10.1371/journal.pone.0112359, PubMed 25390695
84. Abdelnoor M, Sandven I, Limalanathan S, Eritsland J (2014)
    Postconditioning in ST-elevation myocardial infarction: a systematic review, critical appraisal, and meta-analysis of randomized clinical trials
    Vasc Health Risk Manag, 10, 477-91
    DOI 10.2147/VHRM.S67154, PubMed 25143742
85. Stær-Jensen H, Sunde K, Olasveengen TM, Jacobsen D, Drægni T, Nakstad ER, Eritsland J, Andersen GØ (2014)
    Bradycardia during therapeutic hypothermia is associated with good neurologic outcome in comatose survivors of out-of-hospital cardiac arrest
    Crit Care Med, 42 (11), 2401-8
    DOI 10.1097/CCM.0000000000000515, PubMed 25072762
86. Limalanathan S, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P, Eritsland J (2014)
    Effect of ischemic postconditioning on infarct size in patients with ST-elevation myocardial infarction treated by primary PCI results of the POSTEMI (POstconditioning in ST-Elevation Myocardial Infarction) randomized trial
    J Am Heart Assoc, 3 (2), e000679
    DOI 10.1161/JAHA.113.000679, PubMed 24760962
87. Ritschel VN, Seljeflot I, Arnesen H, Halvorsen S, Weiss T, Eritsland J, Andersen GØ (2013)
    IL-6 signalling in patients with acute ST-elevation myocardial infarction
    Results Immunol, 4, 8-13
    DOI 10.1016/j.rinim.2013.11.002, PubMed 24707455
88. Orstavik O, Ata SH, Riise J, Dahl CP, Andersen GØ, Levy FO, Skomedal T, Osnes JB, Qvigstad E (2014)
    Inhibition of phosphodiesterase-3 by levosimendan is sufficient to account for its inotropic effect in failing human heart
    Br J Pharmacol, 171 (23), 5169-81
    DOI 10.1111/bph.12647, PubMed 24547784
89. Andersen GØ (2014)
    Circulatory shock
    N Engl J Med, 370 (6), 583
    DOI 10.1056/NEJMc1314999, PubMed 24499234
90. Majak P, Lunde IG, Hasic AK, Husebye T, Christensen G, Tønnessen T, Bjørnstad JL (2014)
    Reduced visfatin levels in aortic stenosis increase after aortic valve replacement and may contribute to reverse left ventricular remodelling
    J Cardiovasc Surg (Torino), 56 (3), 483-92
    PubMed 24429804
91. Moltzau LR, Meier S, Aronsen JM, Afzal F, Sjaastad I, Skomedal T, Osnes JB, Levy FO, Qvigstad E (2014)
    Differential regulation of C-type natriuretic peptide-induced cGMP and functional responses by PDE2 and PDE3 in failing myocardium
    Naunyn Schmiedebergs Arch Pharmacol, 387 (5), 407-17
    DOI 10.1007/s00210-013-0953-1, PubMed 24424715
92. Bach T, Bergholtz S, Riise J, Qvigstad E, Skomedal T, Osnes JB, Levy FO (2013)
    Identification of small molecule NPR-B antagonists by high throughput screening--potential use in heart failure
    Naunyn Schmiedebergs Arch Pharmacol, 387 (1), 5-14
    DOI 10.1007/s00210-013-0940-6, PubMed 24297249
93. Limalanathan S, Eritsland J, Andersen GØ, Kløw NE, Abdelnoor M, Hoffmann P (2013)
    Myocardial salvage is reduced in primary PCI-treated STEMI patients with microvascular obstruction, demonstrated by early and late CMR
    PLoS One, 8 (8), e71780
    DOI 10.1371/journal.pone.0071780, PubMed 23977143
94. Limalanathan S, Eritsland J (2013)
    What is the optimal cardioprotective treatment of reperfusion injury?
    Cardiology, 125 (2), 131-2
    DOI 10.1159/000351091, PubMed 23711997
95. Husebye T, Eritsland J, Müller C, Sandvik L, Arnesen H, Seljeflot I, Mangschau A, Bjørnerheim R, Andersen GØ (2013)
    Levosimendan in acute heart failure following primary percutaneous coronary intervention-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, placebo-controlled study
    Eur J Heart Fail, 15 (5), 565-72
    DOI 10.1093/eurjhf/hfs215, PubMed 23288914
96. Brattelid T, Qvigstad E, Moltzau LR, Bekkevold SV, Sandnes DL, Birkeland JA, Skomedal T, Osnes JB, Sjaastad I, Levy FO (2012)
    The cardiac ventricular 5-HT4 receptor is functional in late foetal development and is reactivated in heart failure
    PLoS One, 7 (9), e45489
    DOI 10.1371/journal.pone.0045489, PubMed 23029047
97. Abdelnoor M, Eritsland J, Brunborg C, Halvorsen S (2012)
    Ethnicity and acute myocardial infarction: risk profile at presentation, access to hospital management, and outcome in Norway
    Vasc Health Risk Manag, 8, 505-15
    DOI 10.2147/VHRM.S33627, PubMed 22956878
98. Riise J, Ørstavik Ø, Qvigstad E, Dahl CP, Osnes JB, Skomedal T, Levy FO, Krobert KA (2012)
    Prostaglandin E1 facilitates inotropic effects of 5-HT4 serotonin receptors and β-adrenoceptors in failing human heart
    Basic Res Cardiol, 107 (5), 295
    DOI 10.1007/s00395-012-0295-z, PubMed 22923058
99. Majak P, Bjørnstad JL, Braathen B, Lunde IG, Husebye T, Christensen G, Tønnessen T (2012)
    Endothelin-1 in the human myocardium and circulating plasma: evaluation before, during and after correction of aortic stenosis with aortic valve replacement
    Cardiology, 123 (1), 1-10
    DOI 10.1159/000339756, PubMed 22907118
100. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GO (2011)
     Impact of newly diagnosed abnormal glucose regulation on long-term prognosis in low risk patients with ST-elevation myocardial infarction: A follow-up study
     BMC Endocr Disord, 11, 14
     DOI 10.1186/1472-6823-11-14, PubMed 21801387
101. Tømte O, Andersen GØ, Jacobsen D, Drægni T, Auestad B, Sunde K (2011)
     Strong and weak aspects of an established post-resuscitation treatment protocol-A five-year observational study
     Resuscitation, 82 (9), 1186-93
     DOI 10.1016/j.resuscitation.2011.05.003, PubMed 21636202
102. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2011)
     Elevated levels of PAI-1 activity and t-PA antigen are associated with newly diagnosed abnormal glucose regulation in patients with ST-elevation myocardial infarction
     J Thromb Haemost, 9 (8), 1468-74
     DOI 10.1111/j.1538-7836.2011.04377.x, PubMed 21624046
103. Ueland T, Aukrust P, Dahl CP, Husebye T, Solberg OG, Tønnessen T, Aakhus S, Gullestad L (2011)
     Osteoprotegerin levels predict mortality in patients with symptomatic aortic stenosis
     J Intern Med, 270 (5), 452-60
     DOI 10.1111/j.1365-2796.2011.02393.x, PubMed 21623962
104. Bendz B, Endresen K, Eritsland J, Arnesen H (2011)
     [Don't withdraw all blood platelet inhibitors]
     Tidsskr Nor Laegeforen, 131 (8), 800; author reply 800
     DOI 10.4045/tidsskr.11.0278, PubMed 21556070
105. Andersen GØ, Ueland T, Knudsen EC, Scholz H, Yndestad A, Sahraoui A, Smith C, Lekva T, Otterdal K, Halvorsen B, Seljeflot I, Aukrust P (2011)
     Activin A levels are associated with abnormal glucose regulation in patients with myocardial infarction: potential counteracting effects of activin A on inflammation
     Diabetes, 60 (5), 1544-51
     DOI 10.2337/db10-1493, PubMed 21464440
106. Søraas CL, Larstorp AC, Mangschau A, Tønnessen T, Kjeldsen SE, Bjørnerheim R (2011)
     Echocardiographic demonstration of improved myocardial function early after coronary artery bypass graft surgery
     Interact Cardiovasc Thorac Surg, 12 (6), 946-51
     DOI 10.1510/icvts.2010.260414, PubMed 21422155
107. Stensaeth KH, Hoffmann P, Fossum E, Mangschau A, Sandvik L, Klow NE (2011)
     Cardiac magnetic resonance visualizes acute and chronic myocardial injuries in myocarditis
     Int J Cardiovasc Imaging, 28 (2), 327-35
     DOI 10.1007/s10554-011-9812-7, PubMed 21347598
108. Andersen GØ, Knudsen EC, Aukrust P, Yndestad A, Oie E, Müller C, Seljeflot I, Ueland T (2011)
     Elevated serum osteoprotegerin levels measured early after acute ST-elevation myocardial infarction predict final infarct size
     Heart, 97 (6), 460-5
     DOI 10.1136/hrt.2010.206714, PubMed 21270073
109. Weiss TW, Eritsland J (2011)
     Anterior or inferior?
     Wien Klin Wochenschr, 123 (9-10), 268
     DOI 10.1007/s00508-010-1521-z, PubMed 21253773
110. Schwartz T, Sanner H, Husebye T, Flatø B, Sjaastad I (2011)
     Cardiac dysfunction in juvenile dermatomyositis: a case-control study
     Ann Rheum Dis, 70 (5), 766-71
     DOI 10.1136/ard.2010.137968, PubMed 21216816
111. Tømte Ø, Drægni T, Mangschau A, Jacobsen D, Auestad B, Sunde K (2011)
     A comparison of intravascular and surface cooling techniques in comatose cardiac arrest survivors
     Crit Care Med, 39 (3), 443-9
     DOI 10.1097/CCM.0b013e318206b80f, PubMed 21169821
112. Eritsland J, Fossum E (2010)
     Chronic occlusion of the left main coronary artery: importance of collaterals
     Cardiology, 117 (2), 128-30
     DOI 10.1159/000321264, PubMed 20975264
113. Knudsen EC, Seljeflot I, Michael A, Eritsland J, Mangschau A, Müller C, Arnesen H, Andersen GØ (2010)
     Increased levels of CRP and MCP-1 are associated with previously unknown abnormal glucose regulation in patients with acute STEMI: a cohort study
     Cardiovasc Diabetol, 9, 47
     DOI 10.1186/1475-2840-9-47, PubMed 20809989
114. Limalanathan S, Andersen GØ, Hoffmann P, Kløw NE, Abdelnoor M, Eritsland J (2010)
     Rationale and design of the POSTEMI (postconditioning in ST-elevation myocardial infarction) study
     Cardiology, 116 (2), 103-9
     DOI 10.1159/000316965, PubMed 20588018
115. Tjugen TB, Eritsland J, Mangschau A, Andersen GØ (2010)
     [A man in his sixties with myocardial infarction, stent thrombosis and haemorrhage]
     Tidsskr Nor Laegeforen, 130 (6), 613-5
     DOI 10.4045/tidsskr.09.0320, PubMed 20349007
116. Weiss TW, Stensaeth KH, Eritsland J (2009)
     Myocarditis in a juvenile patient with influenza A virus infection
     Eur Heart J, 31 (3), 277
     DOI 10.1093/eurheartj/ehp566, PubMed 20007610
117. Halvorsen S, Eritsland J, Abdelnoor M, Holst Hansen C, Risøe C, Midtbø K, Bjørnerheim R, Mangschau A (2009)
     Gender differences in management and outcome of acute myocardial infarctions treated in 2006-2007
     Cardiology, 114 (2), 83-8
     DOI 10.1159/000216582, PubMed 19420934
118. Knudsen EC, Seljeflot I, Abdelnoor M, Eritsland J, Mangschau A, Arnesen H, Andersen GO (2009)
     Abnormal glucose regulation in patients with acute ST- elevation myocardial infarction-a cohort study on 224 patients
     Cardiovasc Diabetol, 8, 6
     DOI 10.1186/1475-2840-8-6, PubMed 19183453
119. Hofstad B, Nesbakken A, Eritsland J, Brørs O, Sandset PM (2008)
     [Should platelet inhibitors be discontinued before gastrointestinal endoscopy?]
     Tidsskr Nor Laegeforen, 128 (21), 2440-2
     PubMed 19096466
120. Weiss TW, Eritsland J (2011)
     ECG in acute myocardial infarction - inferior not anterior but left and right Reply
     Wien. Klin. Wochen., 123 (15-16), 520
121. Eritsland J, Andersen GO (2019)
     MR findings of microvascular perfusion in infarcted and remote myocardium early after successful primary PCI (vol 13, e0206723, 2018)
     PLoS One, 14 (3), e0213636
     DOI 10.1371/journal.pone.0213636